Literature DB >> 21800415

MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: a Children's Oncology Group (COG) study.

Thien N Sam1, John H Kersey, Amy M Linabery, Kimberly J Johnson, Nyla A Heerema, Joanne M Hilden, Stella M Davies, Gregory H Reaman, Julie A Ross.   

Abstract

BACKGROUND: Infant leukemias have a high frequency of mixed lineage leukemia (MLL) gene rearrangements. PROCEDURE: Using data from a large etiologic study, we evaluated the distribution of selected demographic factors among 374 infant leukemia cases by leukemic subtype, MLL status and diagnosis age.
RESULTS: Overall, 228 cases were MLL+. Compared to white infants, black infants were significantly less likely to have MLL+ leukemia. Further, there was a statistically significantly higher age at diagnosis for infants with t(9;11) translocations compared to all other translocation partners in both acute lymphoblastic leukemia and acute myeloid leukemia cases.
CONCLUSION: These patterns may provide important etiological insight into the biology of infant leukemia.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800415      PMCID: PMC3208122          DOI: 10.1002/pbc.23274

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  22 in total

Review 1.  MLL rearrangements in infant leukemia: is there a higher frequency in females?

Authors:  J A Ross; L L Robison
Journal:  Leuk Res       Date:  1997-08       Impact factor: 3.156

2.  Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.

Authors:  M W J C Jansen; L Corral; V H J van der Velden; R Panzer-Grümayer; M Schrappe; A Schrauder; R Marschalek; C Meyer; M L den Boer; W J C Hop; M G Valsecchi; G Basso; A Biondi; R Pieters; J J M van Dongen
Journal:  Leukemia       Date:  2007-02-01       Impact factor: 11.528

3.  Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California.

Authors:  Melinda C Aldrich; Luoping Zhang; Joseph L Wiemels; Xiaomei Ma; Mignon L Loh; Catherine Metayer; Steve Selvin; James Feusner; Martyn T Smith; Patricia A Buffler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-03       Impact factor: 4.254

4.  11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.

Authors:  C H Pui; F G Behm; J R Downing; M L Hancock; S A Shurtleff; R C Ribeiro; D R Head; H H Mahmoud; J T Sandlund; W L Furman
Journal:  J Clin Oncol       Date:  1994-05       Impact factor: 44.544

5.  Trends in childhood cancer incidence in the U.S. (1992-2004).

Authors:  Amy M Linabery; Julie A Ross
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

6.  Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.

Authors:  P H Sorensen; C S Chen; F O Smith; D C Arthur; P H Domer; I D Bernstein; S J Korsmeyer; G D Hammond; J H Kersey
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

7.  A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy.

Authors:  Weili Chen; Quanzhi Li; Wendy A Hudson; Ashish Kumar; Nicole Kirchhof; John H Kersey
Journal:  Blood       Date:  2006-03-21       Impact factor: 22.113

Review 8.  Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.

Authors:  Tanzina Chowdhury; Hugh J M Brady
Journal:  Blood Cells Mol Dis       Date:  2007-10-01       Impact factor: 3.039

9.  Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups.

Authors:  J A Ross; R K Severson; B H Pollock; L L Robison
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

10.  A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

Authors:  Rob Pieters; Martin Schrappe; Paola De Lorenzo; Ian Hann; Giulio De Rossi; Maria Felice; Liisa Hovi; Thierry LeBlanc; Tomasz Szczepanski; Alice Ferster; Gritta Janka; Jeffrey Rubnitz; Lewis Silverman; Jan Stary; Myriam Campbell; Chi-Kong Li; Georg Mann; Ram Suppiah; Andrea Biondi; Ajay Vora; Maria Grazia Valsecchi
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

View more
  5 in total

1.  Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report.

Authors:  Julie A Ross; Amy M Linabery; Crystal N Blommer; Erica K Langer; Logan G Spector; Joanne M Hilden; Nyla A Heerema; Gretchen A Radloff; Richard L Tower; Stella M Davies
Journal:  Pediatr Blood Cancer       Date:  2012-03-15       Impact factor: 3.167

2.  Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.

Authors:  Erin H Breese; Corina Buechele; Catherine Dawson; Michael L Cleary; Matthew H Porteus
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 3.  Cancer cluster investigations: review of the past and proposals for the future.

Authors:  Michael Goodman; Judy S LaKind; Jerald A Fagliano; Timothy L Lash; Joseph L Wiemels; Deborah M Winn; Chirag Patel; Juliet Van Eenwyk; Betsy A Kohler; Enrique F Schisterman; Paul Albert; Donald R Mattison
Journal:  Int J Environ Res Public Health       Date:  2014-01-28       Impact factor: 3.390

Review 4.  MLL-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy?

Authors:  Oliver Britten; Denise Ragusa; Sabrina Tosi; Yasser Mostafa Kamel
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

5.  Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis.

Authors:  Thomas Milan; Magalie Celton; Karine Lagacé; Élodie Roques; Safia Safa-Tahar-Henni; Eva Bresson; Anne Bergeron; Josée Hebert; Soheil Meshinchi; Sonia Cellot; Frédéric Barabé; Brian T Wilhelm
Journal:  Haematologica       Date:  2022-01-01       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.